Acting on sex and gender in medical innovation is good for business.
Vijayasingham, L
; Bischof, E; Ateghang-Awankem, B; Rumaney, M; Otmani Del Barrio, M; Cheah, PY; Ter-Meulen, AS; Tannenbaum, C; Morgan, R; Wolfe, J; +1 more...Gender and Covid-19 Research Agenda Setting Initiative and
(2023)
Acting on sex and gender in medical innovation is good for business.
BMJ (Clinical research ed.), 381.
e072242-.
ISSN 0959-8138
DOI: 10.1136/bmj-2022-072242
; Bischof, E; Ateghang-Awankem, B; Rumaney, M; Otmani Del Barrio, M; Cheah, PY; Ter-Meulen, AS; Tannenbaum, C; Morgan, R; Wolfe, J; +1 more...Gender and Covid-19 Research Agenda Setting Initiative and
(2023)
Acting on sex and gender in medical innovation is good for business.
BMJ (Clinical research ed.), 381.
e072242-.
ISSN 0959-8138
DOI: 10.1136/bmj-2022-072242
Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits
-
picture_as_pdf - Vijayasingham-etal-2023-Acting-on-sex-and-gender-in-medical-innovation.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 4.0
Downloads